Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Apr 24, 2024, 4:00 PM
1.630
-0.030 (-1.81%)
After-hours: Apr 24, 2024, 7:17 PM EDT
Milestone Pharmaceuticals Stock Forecast
MIST's stock price has decreased by -57.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MIST stock have an average target of 11.33, with a low estimate of 4.00 and a high estimate of 25. The average target predicts an increase of 582.53% from the current stock price of 1.66.
Analyst Consensus: Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
The average analyst rating for MIST stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,406.02% | Mar 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +201.20% | Mar 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,406.02% | Feb 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,406.02% | Aug 14, 2023 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $8 → $4 | Strong Buy → Hold | Downgrades | $8 → $4 | +140.96% | Jun 20, 2023 |
Financial Forecast
Revenue This Year
n/a
from 1.00M
Revenue Next Year
13.77M
EPS This Year
-1.17
from -1.39
EPS Next Year
-1.58
from -1.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 43.3M | 175.0M | 301.0M | 409.6M |
| Avg | n/a | 13.8M | 89.3M | 209.8M | 340.0M |
| Low | n/a | n/a | 8.2M | 161.3M | 271.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,171.2% | 237.1% | 95.3% |
| Avg | - | - | 548.5% | 134.9% | 62.1% |
| Low | - | - | -40.2% | 80.6% | 29.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.85 | -0.69 | 0.56 |
| Avg | -1.17 | -1.58 | -0.53 |
| Low | -1.56 | -2.31 | -1.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.